Review article: Drug development in inflammatory bowel disease: Budesonide - A model of targeted therapy

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 11, Issue 3, 1997, Pages 98-108

  Hamedani, R ^a   Feldman, R D ^a   Feagan, B G ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BUDESONIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; PREDNISOLONE;

ADRENAL SUPPRESSION; CHEMICAL MODIFICATION; CLINICAL TRIAL; CROHN DISEASE; CUSHING DISEASE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; DRUG TARGETING; ENTERITIS; HUMAN; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; ULCERATIVE COLITIS;

EID: 0031453660     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.1997.tb00814.x     Document Type: Review

References (49)